A4 Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-471
Closed -$234K – 91
2026
Q2
$234K Buy
+471
New +$209K 0.16% 81

Other funds holding VRTX

A4 Wealth Advisors's VRTX Position: Q3 2026 in Review

A4 Wealth Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 471 shares — an estimated $234K sold.

A4 Wealth Advisors first reported a position in VRTX in Q2 2026 and held it in 1 quarter. The position peaked at $234K in Q2 2026. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • A4 Wealth Advisors reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • A4 Wealth Advisors sold 471 Vertex Pharmaceuticals shares in Q3 2026, an estimated $234K.
  • A4 Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • A4 Wealth Advisors's Vertex Pharmaceuticals position peaked at $234K in Q2 2026.
  • 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on A4 Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.